Maple-Brown Abbott – 2025 Pinnacle Insights Series – Australian Markets

This presentation is prepared and issued by Maple-Brown Abbott Limited ABN 73 001 208 564, AFSL 237296 (‘MBA’) as the Responsible Entity of the MBA Australian Value Opportunities Fund (ARSN 091 138 233) and the MBA Australian Share Fund – Wholesale (ARSN 087 294 504) (‘Funds’). This presentation contains general information only, and does not take into account your investment objectives, fi nancial situation or specific needs. Before making any investment decision, you should seek independent financial advice. This document does not c onstitute an offer
or solicitation by anyone in any jurisdiction. Past performance is not a reliable indicator of future performance. Neither MBA, nor any of its related parties, directors or employees, make any representation or give any guarantee as to the return of capital, performance, any specific rate of return, or the taxation consequences of, any investment.

Any views expressed on individual stocks or other investments, or any forecasts or estimates, are not a recommendation to buy, sell or hold, they are point in time views and may be based on certain assumptions and qualifications not set out in part or in full in this document. Individual stocks referred to may or may not be currently held by the Fund. Information derived from sources is believed to be accurate, howeve r such information has not been independently verified and may be subject to assumptions and qualifications not described in this document. To the extent permitted by law, neither MBA, nor any of its related parties, directors or employees, make any representation or warranty as to the ac curacy, completeness, reasonableness or reliability of this information, or accept liability or responsibility for any losses, whether direct, indirect or consequential, relating to, or arising from, the use or reliance on this information. Before making a decision whether to acquire, or to continue to hold an investment in the Funds, investors should obtain and consider the current PDS and Target Market Determination (TMD) or any other relevant disclosure document.

For the Fund, the PDS, AIB and TMD are available at maple-brownabbott.com/document-library or by calling 1300 097 995.

This information is current as of 6 March 2025 and is subject to change at any time without notice.

© 2025 Maple-Brown Abbott Limited